TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment Options for NLPHL
Source: Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: February 12, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Nodular Lymphocyte–Predominant HL (NLPHL)
Treatment options for NLPHL include:
Watchful waiting/active surveillance.
Source links and citations
Radiation therapy (early stage).
Source links and citations
Chemotherapy (advanced stage).
Source links and citations
Rituximab.
Source links and citations
Continue within this section
Preserved source evidence · Not medical advice